Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.

ABSTRACT:

Background

Patient safety is a critical concern in clinical oncology, but the ability to measure adverse events (AEs) across cancer care is limited by a narrow focus on treatment-related toxicities. The objective of this study was to assess the nature and extent of AEs among cancer patients across inpatient and outpatient settings.

Methods

This was a retrospective cohort study of 400 adult patients selected by stratified random sampling who had breast (n = 128), colorectal (n = 136), or lung cancer (n = 136) treated at a comprehensive cancer center in 2012. Candidate AEs, or injuries due to medical care, were identified by trained nurse reviewers over the course of 1 year from medical records and safety-reporting databases. Physicians determined the AE harm severity and the

SUBMITTER: Lipitz-Snyderman A 

PROVIDER: S-EPMC7539686 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature